MED Platform II, managed by ArchiMed SAS, agreed to acquire ARK Diagnostics, Inc. from Soulbrain Holdings Co., Ltd. (KOSDAQ:A036830) for approximately KRW 610 billion on September 5, 2025. A cash consideration of KRW 475.56 billion will be paid by the buyer. Along with cash, the consideration consists of 61 million common equity of the buyer having a value of KRW 84.95 billion to be issued for common equity and non-convertible debt (loan) of the buyer having a value of KRW 46.42 billion to be issued for common equity of ARK Diagnostics, Inc. As part of consideration, KRW 606.94 billion is paid towards common equity of ARK Diagnostics, Inc.
For the period ending December 31, 2024, ARK Diagnostics, Inc. reported total revenue of KRW 81.63 billion and net income of KRW 43.95 billion. As of December 31, 2024, ARK Diagnostics, Inc. reported total assets of KRW 190.06 billion and total common equity of KRW 185.76 billion.
The transaction is expected to close on October 23, 2025.
Michael Darby, Alain Decombe, Ani Ravi, Marion Provost, Clemens York, Beverly Ang, Kevin Zaragoza, and Kevin Kay of Dechert (Paris) LLP acted as legal advisor to ArchiMed SAS.
MED Platform II, managed by ArchiMed SAS, completed the acquisition of ARK Diagnostics, Inc. from Soulbrain Holdings Co., Ltd. (KOSDAQ:A036830) for approximately KRW 600 billion on October 23, 2025. The consideration was revised to KRW 603.4 billion. The consideration is structured as KRW 473.57 billion will be paid in cash, KRW 83.42 billion will be covered through equity issuance, and KRW 46.42 billion will be financed via a loan.
Solbrain Holdings Co Ltd, formerly Solbrain Co Ltd, is a Korea-based company mainly engaged in the manufacture and sale of semiconductor and electronic related chemical materials. The Company operates its business through three segments. The Semiconductor Material segment is engaged in the manufacture and sale of chemical mechanical polishing equipment and devices used in semiconductor manufacturing processes, such as chemical mechanical polishing (CMP) slurries and precursors. The Display Materials segment produces and supplies chemical materials for display manufacturing processes such as etchants and mobile-related products such as thin glasses. The Other segment is mainly engaged in the manufacture and sale of chemical materials for secondary battery manufacturing processes. The Company sells its products in domestic and overseas markets such as the United States, China, and Malaysia.
